COVID SAFE: COVID-19 Screening Assessment for Exposure

Completed

Conditions studied: Covid19

In brief

In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balancing program effectiveness, feasibility, costs, and scalability. This study will evaluate the implementation of a COVID-19 screening program that coordinates several existing systems at the University of Pennsylvania including saliva-based viral testing.

Key facts

Study ID

NCT04508777

Run by

University of Pennsylvania

People needed

1759

Starts

2020-09-09

Expected to finish

2021-06-23

Last updated by the study team

2022-03-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be 18 years or older
• University of Pennsylvania faculty, staff, or trainee
• Have a phone or device capable of receiving text messages
• Willing to participate in the study for 6 months

You may not qualify if…

• Participants will not be eligible if they identify any reason they are unable to participate in the study.

Where it is running

• Penn Medicine — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.